Vitrolife AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 848 million compared to SEK 798 million a year ago. Net income was SEK 122 million compared to SEK 108 million a year ago. Basic earnings per share from continuing operations was SEK 0.9 compared to SEK 0.8 a year ago.
For the nine months, sales was SEK 2,607 million compared to SEK 2,379 million a year ago. Net income was SEK 328 million compared to SEK 320 million a year ago. Basic earnings per share from continuing operations was SEK 2.42 compared to SEK 2.36 a year ago.